Karyopharm Therapeutics Inc (NASDAQ:KPTI)
| 19.75 BATS BZX Real-Time Price As of 10:24am ET |  -0.29 / -1.45%Today’s Change | 4.26 Today|||52-Week Range 29.61 | +3.03% Year-to-Date |
Latest KPTI News | Press Releases
No recent news for Karyopharm Therapeutics Inc.
Today’s Trading
| Previous close | 20.04 |
| Today’s open | 19.87 |
| Day’s range | 18.70 - 20.09 |
| Volume | 15,888 |
| Average volume (3 months) | 1,590,840 |
| Market cap | $1.4B |
Data as of 10:24am ET, 03/31/2020
Growth & Valuation
| Earnings growth (last year) | -2.56% |
| Earnings growth (this year) | +30.09% |
| Earnings growth (next 5 years) | -49.42% |
| Revenue growth (last year) | +34.80% |
| P/E ratio | NM |
| Price/Sales | 29.04 |
| Price/Book | 25.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TBPHTheravance Biopharma... | +0.16 | +0.69% |
| AKCAAkcea Therapeutics I... | +0.24 | +1.63% |
| PCRXPacira Biosciences I... | +0.20 | +0.60% |
| ZGNXZogenix Inc | -0.37 | -1.44% |
Data as of 10:23am ET, 03/31/2020
Financials
| Next reporting date | May 7, 2020 |
| EPS forecast (this quarter) | -$0.69 |
| Annual revenue (last year) | $40.9M |
| Annual profit (last year) | -$199.6M |
| Net profit margin | -488.08% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newton, Massachusetts |
Forecasts
